Advanced Biomed Inc. (ADVB) filed an amendment to its certificate of incorporation on February 3, 2026, to effect a 1-for-20 reverse stock split. The reverse stock split became effective, and common stock began trading on a post-split basis, at the open of trading on The Nasdaq Capital Market on February 20, 2026. Every twenty (20) shares of issued and outstanding common stock were automatically converted into one (1) share, without changing the par value of $0.001 per share. No fractional shares were issued; stockholders who would have received fractional shares were rounded up to the next whole share. The company's authorized shares remain unchanged. Following the reverse stock split, the total issued and outstanding common shares changed from 27,290,710 to approximately 1,364,536. The objective of the reverse split is to enable the company to regain compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share. The common stock continues to trade under the symbol ADVB with a new CUSIP number, 00752P203.